+

WO2002038810A3 - Compositions et methodes concernant des genes et des proteines specifiques de la prostate - Google Patents

Compositions et methodes concernant des genes et des proteines specifiques de la prostate Download PDF

Info

Publication number
WO2002038810A3
WO2002038810A3 PCT/US2001/047001 US0147001W WO0238810A3 WO 2002038810 A3 WO2002038810 A3 WO 2002038810A3 US 0147001 W US0147001 W US 0147001W WO 0238810 A3 WO0238810 A3 WO 0238810A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
compositions
antagonists
nucleic acids
agonists
Prior art date
Application number
PCT/US2001/047001
Other languages
English (en)
Other versions
WO2002038810A2 (fr
Inventor
Yongming Sun
Herve Recipon
Sei-Yu Chen
Chenghua Liu
Original Assignee
Diadexus Inc
Yongming Sun
Herve Recipon
Sei-Yu Chen
Chenghua Liu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc, Yongming Sun, Herve Recipon, Sei-Yu Chen, Chenghua Liu filed Critical Diadexus Inc
Priority to AU2002235164A priority Critical patent/AU2002235164A1/en
Publication of WO2002038810A2 publication Critical patent/WO2002038810A2/fr
Publication of WO2002038810A3 publication Critical patent/WO2002038810A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L invention concerne des acides nucléiques récemment identifiés et polypeptides présents dans des cellules normales et néoplasiques de la prostate comprenant des fragments, des variants et des dérivés desdits acides nucléiques et polypeptides. L'invention concerne également des anticorps contre les polypeptides de l'invention, ainsi que des agonistes et des antagonistes de ces polypeptides. L'invention concerne, en outre, des compositions comprenant lesdits acides nucléiques, polypeptides, anticorps, variants, dérivés, agonistes et antagonistes de l'invention, et des méthodes d'utilisation de ces compositions. On utilise lesdites compositions pour identifier, diagnostiquer, surveiller, classer par stade, former des images, et traiter le cancer de la prostate ainsi que des états de maladies non cancéreuses du tissu prostatique; pour identifier et surveiller le tissu prostatique; et pour identifier et/ou concevoir des agonistes et des antagonistes des polypeptides de l'invention. On peut également utiliser ces compositions en thérapie génique, dans la production d'animaux et de cellules transgéniques, et dans la production de tissu prostatique mis au point pour un traitement ou pour la recherche.
PCT/US2001/047001 2000-11-06 2001-11-06 Compositions et methodes concernant des genes et des proteines specifiques de la prostate WO2002038810A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002235164A AU2002235164A1 (en) 2000-11-06 2001-11-06 Compositions and methods relating to prostate specific genes and proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24610900P 2000-11-06 2000-11-06
US60/246,109 2000-11-06

Publications (2)

Publication Number Publication Date
WO2002038810A2 WO2002038810A2 (fr) 2002-05-16
WO2002038810A3 true WO2002038810A3 (fr) 2003-12-04

Family

ID=22929338

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047001 WO2002038810A2 (fr) 2000-11-06 2001-11-06 Compositions et methodes concernant des genes et des proteines specifiques de la prostate

Country Status (2)

Country Link
AU (1) AU2002235164A1 (fr)
WO (1) WO2002038810A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0428187D0 (en) * 2004-12-23 2005-01-26 Univ Liverpool Cancer treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060162A1 (fr) * 1998-05-21 1999-11-25 Diadexus Llc Nouveau procede de diagnostic, de surveillance et de stadification du cancer de la prostate
WO2000047773A1 (fr) * 1999-02-09 2000-08-17 Urocor, Inc. Nouveau gene specifique a la prostate servant au diagnostic, au pronostic et au traitement du cancer de la prostate
WO2000058470A1 (fr) * 1999-03-26 2000-10-05 Henry M. Jackson Foundation For The Advancement Of Military Medicine Gene prostatique specifique, famille de genes pcgem1, et methodes d'emploi de pcgem1 pour la detection, le traitement et la prevention du cancer de la prostate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060162A1 (fr) * 1998-05-21 1999-11-25 Diadexus Llc Nouveau procede de diagnostic, de surveillance et de stadification du cancer de la prostate
WO2000047773A1 (fr) * 1999-02-09 2000-08-17 Urocor, Inc. Nouveau gene specifique a la prostate servant au diagnostic, au pronostic et au traitement du cancer de la prostate
WO2000058470A1 (fr) * 1999-03-26 2000-10-05 Henry M. Jackson Foundation For The Advancement Of Military Medicine Gene prostatique specifique, famille de genes pcgem1, et methodes d'emploi de pcgem1 pour la detection, le traitement et la prevention du cancer de la prostate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BUSSEMAKERS M J G ET AL: "DD3: NEW PROSTATE-SPECIFIC GENE, HIGHLY OVEREXPRESSED IN PROSTATE CANCER", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, 1 December 1999 (1999-12-01), pages 5975 - 5979, XP002923011, ISSN: 0008-5472 *
DATABASE EMBL [online] 23 March 2000 (2000-03-23), XP002238709, retrieved from WWW.EBI.AC.UK Database accession no. AP001491 *
HUBERT R S ET AL: "STEAP: A PROSTATE-SPECIFIC CELL-SURFACE ANTIGEN HIGHLY EXPRESSED IN HUMAN PROSTATE TUMORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 25, 7 December 1999 (1999-12-07), pages 14523 - 14528, XP000946864, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
AU2002235164A1 (en) 2002-05-21
WO2002038810A2 (fr) 2002-05-16

Similar Documents

Publication Publication Date Title
WO2002062945A3 (fr) Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
WO2002055735A3 (fr) Compositions et methodes en rapport avec des genes et des proteines specifiques de la prostate
WO2002040672A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux seins
WO2002064741A3 (fr) Compositions et methodes concernant des genes et des proteines specifiques du sein
WO2002040673A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux poumons
WO2002077232A3 (fr) Compositions et methodes relatives a des genes et a des proteines specifiques du sein
WO2004053075A3 (fr) Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein
WO2002042463A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques a la prostate
WO2002064788A3 (fr) Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons
WO2002039431A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques de la prostate
WO2002042776A3 (fr) Compositions contenant des genes et des proteines specifiques a la prostate, et methodes faisant appel a ces genes et proteines
WO2002088375A3 (fr) Compositions et procedes se rapportant aux genes et proteines specifiques au sein
WO2002068645A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques pour le sein
WO2003066877A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques
WO2002048370A3 (fr) Compositions et methodes associees a des genes et a des proteines specifiques du colon
WO2002046224A3 (fr) Compositions et procedes relatifs a des genes et proteines specifiques des poumons
WO2002066605A3 (fr) Compositions et procedes relatifs a des genes et a des proteines specifiques du sein
WO2002077234A3 (fr) Compositions et methodes se rapportant aux genes et aux proteines specifiques du colon
WO2002042460A3 (fr) Compositions et procedes associes a des genes et a des proteines specifiques du colon
WO2002042499A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques a la prostate
WO2002042329A3 (fr) Compositions et methodes se rapportant a des genes prostatiques specifiques et a des proteines
WO2004052290A3 (fr) Compositions, variants d'epissage et procedes concernant des genes et proteines specifiques du sein
WO2002036616A3 (fr) Compositions et methodes associees aux proteines et aux genes propres au sein
WO2002038810A3 (fr) Compositions et methodes concernant des genes et des proteines specifiques de la prostate
WO2003020953A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques du colon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载